Trademark: 88776927
Status Date
Monday, February 28, 2022
Filing Date
Wednesday, January 29, 2020
Published for Opposition
Tuesday, June 2, 2020
Abandoned Date
Monday, February 28, 2022
5 Pharmaceutical preparations, namely, pharmaceutical preparations for the treatment of disorders and conditions of the central nervous system; pharmaceutical preparations, namely, therapeutic delivery agents for the treatment of disorders and conditions of the central nervous system; pharmaceutical products for the prevention and treatment of cancer
Feb 28, 2022
Abandonment Notice E-Mailed - No Use Statement Filed
Feb 28, 2022
Abandonment - No Use Statement Filed
Sep 7, 2021
Applicant/Correspondence Changes (Non-Responsive) Entered
Sep 7, 2021
Teas Change Of Correspondence Received
Sep 7, 2021
Teas Change Of Domestic Representatives Address
Sep 7, 2021
Attorney/Dom.Rep.Revoked And/Or Appointed
Sep 7, 2021
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Sep 7, 2021
Teas Change Of Owner Address Received
Jul 29, 2021
Notice Of Approval Of Extension Request E-Mailed
Jul 27, 2021
Sou Extension 2 Granted
Jul 27, 2021
Sou Extension 2 Filed
Jul 27, 2021
Sou Teas Extension Received
Jan 28, 2021
Notice Of Approval Of Extension Request E-Mailed
Jan 26, 2021
Sou Extension 1 Granted
Jan 26, 2021
Sou Extension 1 Filed
Jan 26, 2021
Sou Teas Extension Received
Jul 28, 2020
Noa E-Mailed - Sou Required From Applicant
Jun 2, 2020
Official Gazette Publication Confirmation E-Mailed
Jun 2, 2020
Published For Opposition
May 13, 2020
Notification Of Notice Of Publication E-Mailed
Apr 28, 2020
Assigned To Lie
Apr 22, 2020
Approved For Pub - Principal Register
Apr 22, 2020
Examiner's Amendment Entered
Apr 22, 2020
Notification Of Examiners Amendment E-Mailed
Apr 22, 2020
Examiners Amendment E-Mailed
Apr 22, 2020
Examiners Amendment -Written
Apr 18, 2020
Assigned To Examiner
Feb 4, 2020
New Application Office Supplied Data Entered
Feb 1, 2020
New Application Entered
Trademark Alertz updated from USPTO on 2030-01-24
